These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The use of mupirocin in controlling methicillin-resistant Staphylococcus aureus. Neu HC. Infect Control Hosp Epidemiol; 1990 Jan 19; 11(1):11-2. PubMed ID: 2105351 [No Abstract] [Full Text] [Related]
11. [In vitro activity of mupirocin, a new topical agent against Staphylococcus aureus]. Rosales Rodríguez M. Enferm Infecc Microbiol Clin; 1990 Nov 19; 8(9):572-3. PubMed ID: 2129195 [Abstract] [Full Text] [Related]
12. Staphylococcus aureus highly resistant to mupirocin is now common in Auckland. Skellem P, Toy G, Lang S. N Z Med J; 1998 Mar 13; 111(1061):82. PubMed ID: 9549560 [No Abstract] [Full Text] [Related]
18. Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study. Biedenbach DJ, Bouchillon SK, Johnson SA, Hoban DJ, Hackel M. Clin Ther; 2014 Jun 01; 36(6):953-60. PubMed ID: 24835558 [Abstract] [Full Text] [Related]
19. Staphylococcus aureus resistant to mupirocin. Smith GE, Kennedy CT. J Antimicrob Chemother; 1988 Jan 01; 21(1):141-2. PubMed ID: 3128519 [No Abstract] [Full Text] [Related]
20. Adaptation of methicillin-resistant Staphylococcus aureus during antibiotic therapy. Menzies RE, Cornere BM, MacCulloch D. J Antimicrob Chemother; 1989 Jun 01; 23(6):923-7. PubMed ID: 2503489 [Abstract] [Full Text] [Related] Page: [Next] [New Search]